These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3108458)

  • 61. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.
    Engel WK; Siddique T; Nicoloff JT
    Lancet; 1983 Jul; 2(8341):73-5. PubMed ID: 6134961
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic transfer of the wobbler gene to a C57BL/6J x NZB hybrid stock: natural history of the motor neuron disease and response to CNTF and BDNF cotreatment.
    Ishiyama T; Klinkosz B; Pioro EP; Mitsumoto H
    Exp Neurol; 1997 Nov; 148(1):247-55. PubMed ID: 9398466
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of the wobbler mouse: a model of motor neuron disease.
    Bonanno G; Fumagalli E; Milanese M; Zappettini S; Mennini T
    Neurochem Int; 2009 Sep; 55(5):302-6. PubMed ID: 19576518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serotonergic regulation of the spinal cord content of thyrotropin releasing hormone in the cerebellar ataxia mutant mouse.
    Endo S; Itoh M; Serizawa O
    J Neurol Sci; 1993 Sep; 118(2):194-201. PubMed ID: 8229069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intrathecal thyrotropin-releasing hormone therapy of amyotrophic lateral sclerosis.
    Stober T; Schimrigk K; Dietzsch S; Thielen T
    J Neurol; 1985; 232(1):13-4. PubMed ID: 3923160
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early Signs of Neuroinflammation in the Postnatal Wobbler Mouse Model of Amyotrophic Lateral Sclerosis.
    Meyer M; Lima A; Deniselle MCG; De Nicola AF
    Cell Mol Neurobiol; 2023 Jul; 43(5):2149-2163. PubMed ID: 36219378
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vacuolated anterior horn cells in wobbler mouse motor neuron disease: peripheral axons and regenerative capacity.
    Mitsumoto H; Boggs AL
    J Neuropathol Exp Neurol; 1987 Mar; 46(2):214-22. PubMed ID: 3819775
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin.
    Festoff BW; D'Andrea MR; Citron BA; Salcedo RM; Smirnova IV; Andrade-Gordon P
    Mol Med; 2000 May; 6(5):410-29. PubMed ID: 10952021
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Abnormal RNA metabolism in spinal motor neurons in the wobbler mouse.
    Murakami T; Mastaglia FL; Mann DM; Bradley WG
    Muscle Nerve; 1981; 4(5):407-12. PubMed ID: 6169987
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Short-term stability of single motor unit recordings in motor neuron disease: a macro EMG study.
    Guiloff RJ; Modarres-Sadeghi H; Stålberg E; Rogers H
    J Neurol Neurosurg Psychiatry; 1988 May; 51(5):671-6. PubMed ID: 3136230
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The microRNA miR-375-3p and the Tumor Suppressor NDRG2 are Involved in Sporadic Amyotrophic Lateral Sclerosis.
    Rohm M; May C; Marcus K; Steinbach S; Theis V; Theiss C; Matschke V
    Cell Physiol Biochem; 2019; 52(6):1412-1426. PubMed ID: 31075191
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Subacute administration of a TRH analogue (RX77368) in motorneuron disease: an open study.
    Modarres-Sadeghi H; Rogers H; Emami J; Guiloff RJ
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1146-57. PubMed ID: 3147318
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Strychnine-sensitive and strychnine-insensitive glycine binding sites in the spinal cord of the wobbler mouse.
    Tomiyama M; Kannari K; Matsunaga M
    Tohoku J Exp Med; 1997 Sep; 183(1):37-43. PubMed ID: 9453115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):207-12. PubMed ID: 11464954
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A thyrotropin-releasing hormone-containing system in the rat dorsal horn separate from serotonin.
    Harkness DH; Brownfield MS
    Brain Res; 1986 Oct; 384(2):323-33. PubMed ID: 3096489
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Biochemistry of motor neurons--in relation to motor neuron diseases].
    Hayashi H
    Nihon Rinsho; 1977 Nov; 35(11):4019-24. PubMed ID: 413955
    [No Abstract]   [Full Text] [Related]  

  • 78. Specific radioimmunoassay of cyclo (His-Pro), a biologically active metabolite of thyrotropin-releasing hormone.
    Mori M; Prasad C; Wilber JF
    Endocrinology; 1981 May; 108(5):1995-7. PubMed ID: 6783397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

  • 80. Plasminogen activators in the neuromuscular system of the wobbler mutant mouse.
    Blondet B; Barlovatz-Meimon G; Festoff BW; Soria C; Soria J; Rieger F; Hantai D
    Brain Res; 1992 May; 580(1-2):303-10. PubMed ID: 1504807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.